CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis

Zhang,Lin; Li,Yingna; Liang,Chunlian; Yang,Weilin

doi:10.3892/ijmm.2013.1565

CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis

Authors:
- Lin Zhang
- Yingna Li
- Chunlian Liang
- Weilin Yang
View Affiliations

Affiliations: Department of Geriatrics, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University,Xi'an, Shaanxi 710004, P.R. China
Published online on: November 25, 2013 https://doi.org/10.3892/ijmm.2013.1565
Pages: 478-486

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with unknown etiology and undefined treatment modality. Fibroblasts are regarded as the major cell type that mediates the onset and progression of lung fibrosis by secreting large amounts of extracellular matrix (ECM) proteins, such as connective tissue growth factor (CTGF/CCN2). Current knowledge confers a crucial role of CCN2 in lung fibrosis. CCN5, another member of the CCN family, has been suggested to play an inhibitory role in some fibrotic diseases, such as cardiac fibrosis. However, the role of CCN5 in the process of IPF remains unknown. In the present study, using western blot analysis, we demonstrate that CCN2 is highly expressed in fibroblasts derived from IPF tissue, but is only slightly expressed in normal human lung fibroblasts. However, CCN5 was weakly expressed in all the above cells. qRT-PCR revealed that transforming growth factor (TGF)-β1 stimulation increased CCN2 expression in the IPF-derived cultures of primary human lung fibroblasts (PIFs) in a time- and concentration-dependent manner, but only slightly affected the expression of CCN5. The overexpression of CCN5 induced by the transfection of PIFs with recombinant plasmid did not affect cell viability, proliferation and apoptosis; however, it significantly suppressed the expression of CCN2, α-smooth muscle actin (α-SMA) and collagen type I. The TGF-β1-induced upregulation of the phosphorylation of Akt was reversed by CCN5 overexpression. Our results also demonstrated that adenovirus-mediated CCN5 overexpression in a mouse model of bleomycin-induced IPF significantly decreased the hydroxyproline content in the lungs, as well as TGF-β1 expression in bronchoalveolar lavage fluid. Taken together, our data demonstrate that CCN5 exerts an inhibitory effect on the fibrotic phenotypes of pulmonary fibroblasts in vitro and in vivo, and as such may be a promising target for the treatment of IPF.

View Figures

View References

1	Huang LS, Berdyshev E, Mathew B, et al: Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. FASEB J. 27:1749–1760. 2013. View Article : Google Scholar : PubMed/NCBI
2	Scotton CJ and Chambers RC: Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest. 132:1311–1321. 2007. View Article : Google Scholar : PubMed/NCBI
3	Singh SR and Hall IP: Airway myofibroblasts and their relationship with airway myocytes and fibroblasts. Proc Am Thorac Soc. 5:127–132. 2008. View Article : Google Scholar : PubMed/NCBI
4	Phan SH: The myofibroblast in pulmonary fibrosis. Chest. 122:286S–289S. 2002. View Article : Google Scholar : PubMed/NCBI
5	Kono M, Nakamura Y, Suda T, et al: Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF). Clin Chim Acta. 412:2211–2215. 2011. View Article : Google Scholar : PubMed/NCBI
6	Fernandez IE and Eickelberg O: The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc. 9:111–116. 2012.
7	Fine A and Goldstein RH: The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem. 262:3897–3902. 1987.PubMed/NCBI
8	Leask A and Abraham DJ: All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 119:4803–4810. 2006. View Article : Google Scholar : PubMed/NCBI
9	Inadera H, Hashimoto S, Dong HY, et al: WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem Biophys Res Commun. 275:108–114. 2000. View Article : Google Scholar : PubMed/NCBI
10	Moussad EE and Brigstock DR: Connective tissue growth factor: what’s in a name? Mol Genet Metab. 71:276–292. 2000.
11	Ponticos M, Holmes AM, Shi-wen X, et al: Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. 60:2142–2155. 2009. View Article : Google Scholar : PubMed/NCBI
12	Brigstock DR: Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J Cell Commun Signal. 4:1–4. 2010. View Article : Google Scholar : PubMed/NCBI
13	Sonnylal S, Shi-Wen X, Leoni P, et al: Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 62:1523–1532. 2010. View Article : Google Scholar : PubMed/NCBI
14	Liu S, Shi-wen X, Abraham DJ and Leask A: CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum. 63:239–246. 2011. View Article : Google Scholar : PubMed/NCBI
15	Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE and Laurent GJ: Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem. 275:35584–35591. 2000. View Article : Google Scholar : PubMed/NCBI
16	Bonniaud P, Martin G, Margetts PJ, et al: Connective tissue growth factor is crucial to inducing a profibrotic environment in ‘fibrosis-resistant’ BALB/c mouse lungs. Am J Respir Cell Mol Biol. 31:510–516. 2004.PubMed/NCBI
17	Fritah A, Redeuilh G and Sabbah M: Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens. J Endocrinol. 191:613–624. 2006. View Article : Google Scholar : PubMed/NCBI
18	Brigstock DR: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev. 20:189–206. 1999.PubMed/NCBI
19	Leask A: Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2. J Cell Commun Signal. 4:155–156. 2010. View Article : Google Scholar : PubMed/NCBI
20	Yoon PO, Lee MA, Cha H, et al: The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol. 49:294–303. 2010. View Article : Google Scholar : PubMed/NCBI
21	Sabbah M, Prunier C, Ferrand N, et al: CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway. Mol Cell Biol. 31:1459–1469. 2011.PubMed/NCBI
22	Ricci A, Cherubini E, Ulivieri A, et al: Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis. J Cell Physiol. 228:235–241. 2013. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
24	Fritah A, Saucier C, De Wever O, et al: Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol. 28:1114–1123. 2008. View Article : Google Scholar : PubMed/NCBI
25	Tsuburai T, Suzuki M, Nagashima Y, et al: Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum Gene Ther. 13:1945–1960. 2002. View Article : Google Scholar : PubMed/NCBI
26	Woessner JF Jr: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 93:440–447. 1961. View Article : Google Scholar : PubMed/NCBI
27	Milam JE, Keshamouni VG, Phan SH, et al: PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 294:L891–901. 2008. View Article : Google Scholar : PubMed/NCBI
28	Kolb M, Margetts PJ, Galt T, et al: Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med. 163:770–777. 2001. View Article : Google Scholar : PubMed/NCBI
29	Conte E, Fruciano M, Fagone E, et al: Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms. PLoS One. 6:e246632011. View Article : Google Scholar : PubMed/NCBI
30	Park S and Lee EJ: Recent advances in idiopathic pulmonary fibrosis. Tuberc Respir Dis (Seoul). 74:1–6. 2013. View Article : Google Scholar
31	Wójcik KA, Skoda M, Koczurkiewicz P, Sanak M, Czyż J and Michalik M: Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations. Pharmacol Rep. 65:164–172. 2013.
32	Wilkes MC, Mitchell H, Penheiter SG, et al: Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res. 65:10431–10440. 2005. View Article : Google Scholar : PubMed/NCBI
33	Martin MM, Buckenberger JA, Jiang J, et al: TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol. 293:L790–L799. 2007. View Article : Google Scholar : PubMed/NCBI
34	Mason HR, Lake AC, Wubben JE, Nowak RA and Castellot JJ Jr: The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol Hum Reprod. 10:181–187. 2004. View Article : Google Scholar : PubMed/NCBI
35	Pennica D, Swanson TA, Welsh JW, et al: WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA. 95:14717–14722. 1998. View Article : Google Scholar : PubMed/NCBI